Shah Gilani's Archive

Shah Gilani
Shah Gilani

Wall Street superstar and former hedge fund manager Shah Gilani is the Chief Investment Strategist of Manward Press and at the helm of the Manward Money Report newsletter and the Launch Investor and Alpha Money Flow trading services. He’s a sought-after market commentator and has appeared on CNBC, Fox Business and Bloomberg TV. He’s also been quoted in The Wall Street Journal, The New York Times and The Washington Post, and he’s had columns published in Forbes.

In 1982, he launched his first hedge fund from his seat on the floor of the Chicago Board Options Exchange. He worked in the pit as a market maker when options on the S&P 100 Index first began trading… and was part of a handful of traders who laid the technical groundwork for what would eventually become the CBOE Volatility Index (VIX). He also ran the futures and options division at the largest retail bank in Britain. Shah gained notoriety for calling the implosion of U.S. financial markets (all the way back in February 2008) AND the mega bull run that followed.

Now at the helm of Manward, Shah is focused tightly on one goal: To do his part to make subscribers wealthier, happier and more free.

Buy This, Not That: This Recession-Proof Favorite Might Be in Trouble

When people start to tighten their belts… their spending shifts from dining out to getting takeout. Let’s look at some of the biggest cooks in the fast-food kitchen.


Monday Takeaways: Misplaced Optimism Could Be Costly

The markets rallied after last week’s big dust-up… but we’re not out of the woods yet. Here’s why.


How to Pick Up Stocks on the Dip

Like any good bargain shopper, we must do our price research before buying stocks on the dip… using my favorite technical tools.


Buy This, Not That: When to Load Back Up on the Magnificent 7

The Magnificent Seven have sold off hard. In this special edition of Buy This, Not That, Shah shows us where the best buying opportunities are.


Monday Takeaways: Sentiment Has Turned… Get Ready to Buy

The Fed’s promise of a rate cut did nothing to calm nerves after a poor job report. Here’s what’s coming…


The Tech Sector Selloff Is All About the Money

The initial AI boom has given way to a more nuanced – and potentially concerning – secondary narrative. Here’s what investors need to know…


Buy This, Not That: Looking for Fertile Profits With These 6 Ag Stocks

The agriculture sector grows and wilts by the changing of the seasons… the weather… and supply/demand. But what about the companies that support the ag business worldwide?


Monday Takeaways: The Number to Watch This Week

Was last week’s late stage rally a sign of things to come… these crucial numbers have the answer.


What’s Really Behind the Surge in Small Caps

After posting quick double-digit gains… the Russell 2000 is begging for a closer look. The truth is… this extraordinary performance raises key questions…


Buy This, Not That: A Big Dose of 5 Big Pharma Stocks

Which of these five drugmakers stocks hands out a prescription for portfolio health?


BROUGHT TO YOU BY MANWARD PRESS